We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+4.01%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$6.7B
AUM Growth
+$144M
Cap. Flow
+$80.4M
Cap. Flow %
1.2%
Top 10 Hldgs %
21%
Holding
1,675
New
169
Increased
710
Reduced
579
Closed
127

Sector Composition

Rank Sector Weight
1 Technology 21.11%
2 Financials 10.66%
3 Industrials 8.29%
4 Consumer Discretionary 7.5%
5 Healthcare 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDX icon
301
Becton Dickinson
BDX
$46.4B
$4.74M 0.07%
20,898
+154
+0.7% +$35.6K
OKE icon
302
Oneok
OKE
$56.7B
$4.71M 0.07%
46,954
-6
-0% -$614
CARR icon
303
Carrier Global
CARR
$49.4B
$4.69M 0.07%
68,776
+2,966
+5% +$224K
TROW icon
304
T. Rowe Price
TROW
$25.5B
$4.67M 0.07%
41,284
-22,152
-35% -$2.57M
CVS icon
305
CVS Health
CVS
$135B
$4.64M 0.07%
103,378
+3,530
+4% +$198K
SPYV icon
306
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.2B
$4.62M 0.07%
+90,407
New +$4.81M
PAVE icon
307
Global X US Infrastructure Development ETF
PAVE
$13.5B
$4.62M 0.07%
114,278
+15,667
+16% +$671K
ULTA icon
308
Ulta Beauty
ULTA
$21.8B
$4.6M 0.07%
10,587
+680
+7% +$263K
SMH icon
309
VanEck Semiconductor ETF
SMH
$60.8B
$4.59M 0.07%
18,951
-5,323
-22% -$1.32M
BN icon
310
Brookfield
BN
$102B
$4.59M 0.07%
119,769
+68,569
+134% +$2.58M
EME icon
311
Emcor
EME
$29.9B
$4.58M 0.07%
10,093
+935
+10% +$442K
IWO icon
312
iShares Russell 2000 Growth ETF
IWO
$14.1B
$4.58M 0.07%
15,907
+511
+3% +$151K
BG icon
313
Bunge Global
BG
$20.9B
$4.54M 0.07%
58,429
-3,397
-5% -$298K
INTC icon
314
Intel
INTC
$413B
$4.54M 0.07%
226,206
-35,662
-14% -$804K
DOV icon
315
Dover
DOV
$26.7B
$4.47M 0.07%
23,831
+5,289
+29% +$1.03M
AER icon
316
AerCap
AER
$23.4B
$4.45M 0.07%
46,499
+10,273
+28% +$985K
CGGR icon
317
Capital Group Growth ETF
CGGR
$23.2B
$4.45M 0.07%
119,595
+12,251
+11% +$450K
EW icon
318
Edwards Lifesciences
EW
$49.4B
$4.44M 0.07%
60,041
+21,855
+57% +$1.53M
PNR icon
319
Pentair
PNR
$10.6B
$4.44M 0.07%
44,159
-2,818
-6% -$289K
WSO icon
320
Watsco Inc
WSO
$13.2B
$4.41M 0.07%
9,311
+813
+10% +$412K
VXUS icon
321
Vanguard Total International Stock ETF
VXUS
$151B
$4.41M 0.07%
74,752
+5,046
+7% +$313K
ECAT icon
322
BlackRock ESG Capital Allocation Term Trust
ECAT
$1.48B
$4.4M 0.07%
268,461
-6,064
-2% -$105K
MDY icon
323
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.4B
$4.37M 0.07%
7,669
+270
+4% +$158K
MLP icon
324
Maui Land & Pineapple Co
MLP
$354M
$4.32M 0.06%
196,765
-1,800
-0.9% -$41.2K
ITW icon
325
Illinois Tool Works
ITW
$84.1B
$4.28M 0.06%
16,884
+563
+3% +$149K

Similar funds

Oppenheimer & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Oppenheimer & Co held 1,675 positions worth $6.7B, up 2.2% from $6.56B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Oppenheimer & Co's Q4 2024 filing shows 169 new, 710 increased, 579 reduced and 127 closed positions. Its largest new stake was FT Vest US Equity Deep Buffer ETF November: 493,441 shares worth $21.2M. The largest sale was FT Vest US Equity Deep Buffer ETF March, an estimated $21.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.

  • Oppenheimer & Co's largest Q4 2024 buy was FT Vest US Equity Deep Buffer ETF November: 493,441 shares worth $21.2M.
  • Oppenheimer & Co added most to iShares Russell Mid-Cap Growth ETF in Q4 2024, an estimated $12.8M increase.
  • Oppenheimer & Co's biggest Q4 2024 reduction was FT Vest US Equity Deep Buffer ETF March, cutting an estimated $21.8M.
  • Oppenheimer & Co fully exited Innovative Industrial Properties in Q4 2024, selling an estimated $6.32M.
  • Oppenheimer & Co's ten largest holdings make up 21% of its $6.7B portfolio in Q4 2024.
  • Oppenheimer & Co opened 169 new positions and closed 127 in Q4 2024.
  • Oppenheimer & Co's portfolio value rose 2.2% quarter-over-quarter to $6.7B.

Based on Oppenheimer & Co's 13F filing for Q4 2024, filed 5 Feb 2025.